Endometrial polyps and the risk of atypical hyperplasia on biopsies of unremarkable endometrium: A study on 694 patients with benign endometrial polyps

International Journal of Gynecological Pathology

Volumn 28, Issue 6, 2009, Pages 522-528

  Rahimi, Siavash ^a   Marani, Carla ^a   Renzi, Cristina ^b   Natale, Maria Emanuela ^a   Giovannini, Paolo ^c   Zeloni, Renato ^c  

^a Ospedale San Carlo IDI IRCCS   (Italy)

^b Epidemiology Unit IDI IRCCS

^c LABORATORIO DI PATOLOGIA VASCOLARE   (Italy)

Author keywords

Atypical endometrial hyperplasia; Endometrial biopsy; Endometrial cancer; Endometrial polyp; Hysteroscopy

Indexed keywords

ADULT; ARTICLE; ATYPICAL ENDOMETRIAL HYPERPLASIA; CANCER SURGERY; DISEASE ASSOCIATION; ENDOMETRIUM; ENDOMETRIUM BIOPSY; ENDOMETRIUM CARCINOMA; ENDOMETRIUM HYPERPLASIA; ENDOMETRIUM POLYP; ENDOSCOPIC SURGERY; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; HYSTEROSCOPY; MAJOR CLINICAL STUDY; POLYPECTOMY; POSTMENOPAUSE; PREMENOPAUSE; PRIORITY JOURNAL; RISK FACTOR; TUMOR VOLUME; AGED; BIOPSY; MIDDLE AGED; PATHOLOGY; POLYP; PRECANCER;

ADULT; AGED; AGED, 80 AND OVER; BIOPSY; ENDOMETRIAL HYPERPLASIA; FEMALE; HUMANS; MIDDLE AGED; POLYPS; PRECANCEROUS CONDITIONS; RISK FACTORS; YOUNG ADULT;

EID: 73949093904     PISSN: 02771691     EISSN: None     Source Type: Journal    
DOI: 10.1097/PGP.0b013e3181a42228     Document Type: Article

References (24)

1. Gimpelson RJ, Rappold HO. A comparative study between panoramic hysteroscopy with directed biopsies and dilatation and curettage. A review of 276 cases. Am J Obstet Gynecol 1988;158:489-492
2. Towbin NA, Gviazda IM, March CM. Office hysteroscopy versus transvaginal ultrasonography in the evaluation of patients with excessive uterine bleeding. Am J Obstet Gynecol 1996;174:1678-1682
3. Haller H, Matecjcic N, Rukavina B, et al. Transvaginal sonography and hysteroscopy in women with postmenopausal bleeding. Int J Gynecol Obstet 1996;54:155-159
4. Loffer FD. Hysteroscopy with selective endometrial sampling compared with D&C for abnormal uterine bleeding: the value of a negative hysteroscopic view. Obstet Gynecol 1989;73:16-20.
5. Saidi MH, Sadler RK, Theis VD, et al. Comparison of sonography, sonohysterography and hysteroscopy for evaluation of abnormal uterine bleeding. J Ultrasound Med 1997;16:587-591
6. Valle RF. Hysteroscopic evaluation of patients with abnormal uterine bleeding. Surg Gynecol Obstet 1981;153:521-526
7. Ben Arie A, Goldchmit C, Laviv Y, et al. The malignant potential of endometrial polyps. Eur J Obstet Gynecol Reprod Biol 2004;115:206-210
8. Sharma M, Taylor A, Magos A. Management of endometrial polyps: a clinical review. Rev Gynaecol Practice 2004;4:1-6.
9. Bakour SH, Khan KS, Gupta JK. The risk of premalignant and malignant pathology in endometrial polyps. Acta Obstet Gynecol Scand 2000;79:317-320
10. Hileeto D, Fadare O, Martel M, et al. Age dependent association of endometrial polyps with increased risk of cancer involvement. World J Surg Oncol 2005;3:8.
11. Scott RB. The elusive endometrial polyp. Obstet Gynecol 1953;1:212-218
12. Fletcher JA, Pinkus JL, Lage JM, et al. Clonal 6p21 rearrangement is restricted to the mesenchymal component of an endometrial polyp. Genes Chromosomes Cancer 1992;5:260-263
13. Dal Cin P, Vanni R, Marras S, et al. Four cytogenetic subgroups can be identified in endometrial polyps. Cancer Res 1995;55:1565-1568
14. Bol S, Wanschura S, Thode B, et al. An endometrial polyp with a rearrangement of HMGI-C underlying a complex cytogenetic rearrangement involving chromosomes 2 and 12. Cancer Genet Cytogenet 1996;90:88-90.
15. Dal Cin P, Wanschura S, Kazmierczak B, et al. Amplification and expression of the HMGIC gene in a benign endometrial polyp. Genes Chromosomes Cancer 1998;22:95-99
16. Tallini G, Vanni R, Manfioletti G, et al. HMGI-C and HMGI(Y) immunoreactivity correlates with cytogenetic abnormalities in lipomas, pulmonary chondroid hamartomas, endometrial polyps, and uterine leiomyomas and is compatible with rearrangement of the HMGI-C and HMGI(Y) genes. Lab Invest 2000;80:359-369
17. Mutter GL, Zaino RJ, Baak JPA, et al. Review: benign endometrial hyperplasia sequence and endometrial intraepithelial neoplasia. Int J Gynecol Pathol 2007;26:103-114
18. Scully RE, Bonfiglio TA, Kurman RJ, et al. Histological typing of female genital tract tumours. In: Kurmin RJ. World Health Organization International Histological Classification of Tumours. 2nd ed. Berlin: Springer-Verlag; 1994:13-15.
19. Skov BG, Broholm H, Engel U, et al. Comparison of the reproducibility of the WHO classifications of 1975 and 1994 of endometrial hyperplasia. Int J Gynaecol Pathol 1997;16:33-37.
20. Zaino RJ, Kauderer J, Trimble CL, et al. Reproducibility of the diagnosis of atypical endometrial hyperplasia: a Gynecologic Oncology Group study. Cancer 2006;106:804-811
21. Allison KH, Reed SD, Voigt LF, et al. Diagnosing endometrial hyperplasia: Why is it so difficult to agree? Am J Surg Pathol 2008;32:691-698
22. Mazur MT, Kurman RJ. Endometrial hyperplasia and epithelial cytoplasmic change. In: Mazur MT, Kurmin RJ. Diagnosis of Endometrial Biopsies Curettings, a Practical Approach. New York: Springer-Verlag; 1995:146-183.
23. Savelli L, De Iaco P, Santini D, et al. Histopathologic features and risk factors for benignity, hyperplasia, and cancer in endometrial polyps. Am J Obstet Gynecol 2003;188:927-931
24. Ramondetta LM, Sherwood JB, Dunton CJ, et al. Endometrial cancer in polyps associated with tamoxifen use. Am J Obstet Gynecol 1999;180:340-341